General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
24-Feb-2025 19:44:50
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG250224OTHRNDN0
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited / Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
24/02/2025 17:13:00
Description (Please provide a detailed description of the event in the box below)
Biocon Biologics Launches Yesintek (ustekinumab-kfce) Biosimilar to Stelara in the United States.

Attachments

BBL_Press Release_Yesintek_24022025.pdf
Total size =484K